Dr Anne Moore with microneedle patches on her hand Image Tomás Tyner
Researchers at UCC have developed a microneedle-based patch that results in increased vaccine-induced protection against malaria infection using lower doses of vaccine in pre-clinical testing.
The lead researcher, Dr Anne Moore, heads to Silicon Valley next week to meet venture capitalists and leading technology companies with a view to commercialising the research.
The microneedle-based patch also overcomes one of the main problems with this type of vaccine which relates to overcoming pre-existing immunity to the vaccine. The scientists combined two vaccine technologies to determine if immunity could be further enhanced and the research suggests that using a microneedle patch would overcome the need to make and use multiple different vaccine types to induce protective immunity to some of the world’s biggest killers. This could have significant consequences on the costs and logistics of vaccination.
The work was carried out by researchers in the School of Pharmacy, Dept. of Pharmacology and the Tyndall National Institute, UCC, led by Dr Anne Moore in collaboration with colleagues at the Jenner Institute, University of Oxford and was published byNature Publication Group in Scientific Reports and funded by Enterprise Ireland and Science Foundation Ireland. Dr Moore’s visit to Silicon Valley is being hosted by the Irish Technology Leadership Group (ITLG) as part of an SFI initiative for researchers to help them develop their entrepreneurial skills in the Get Started Venture Technology programme.
The skin patch has arrays of tiny silicon ‘microneedles’ that painlessly create temporary pores in the very outermost barrier layer of the skin, permitting the vaccine to flow into the skin, which is rich in cells of the immune system. The experimental vaccine was based on a live adenovirus. This virus is similar to those that can cause a common cold, but is engineered to be safer and to deliver a protein from the malaria-causing parasite, to the immune system.
The Latest on: Malaria vaccine
via Google News
The Latest on: Malaria vaccine
- A box of 200 mosquitoes did the vaccinating in this malaria trial. That's not a joke!on September 21, 2022 at 5:59 pm
Volunteers for the trial put an arm over a box with hundreds of mosquitoes carrying a genetically modified malaria parasite. Here's why they did it that way — and why the trial holds promise.
- A box of 200 mosquitoes did the vaccinating in this malaria...on September 21, 2022 at 4:40 pm
She put her arm over a cardboard box filled with 200 mosquitoes and covered with a mesh that keeps them in but still lets them bite. "Literally a Chinese food takeout container" is how she remembers ...
- Seafood carbon footprint, malaria vaccine and a US health chiefon September 21, 2022 at 1:48 am
Malaria vaccine booster prolongs protection. A promising malaria vaccine was up to 80% effective at preventing the disease in young children who received a booster shot one year a ...
- HERALDING THE MALARIA VACCINEon September 19, 2022 at 5:00 pm
With justifiable fanfare, the World Health Organisation (WHO) has announced its endorsement of the first malaria vaccine for children in the world. The vaccine code-named RTS.S and manufactured by ...
- Booster dose of Malaria vaccine after three-dose regimen effective against clinical malariaon September 18, 2022 at 7:30 am
Malaria vaccine is still effective against spread of malaria according to a recent study published in the Lancet Infectious Diseases Malaria is a leading cause of morbidity and mortality ...
- Malaria vaccine: The road has been long and tortuous, but we're getting thereon September 15, 2022 at 8:12 am
A vaccine candidate called R21 has been shown to be up to 80% effective at preventing malaria in young children, according to the latest trial results.
- Could the new malaria vaccine be the most effective way to save lives in history?on September 15, 2022 at 8:05 am
While almost all of the winter deaths will be among the elderly, 80 per cent of those dying of malaria are children. Each death leads to several times the number of years of life lost ...
- Malaria vaccine candidate safe and immunogenic following first-in-human trialson September 14, 2022 at 10:32 am
Researchers from the Walter Reed Army Institute of Research (WRAIR) report the malaria vaccine FMP013 antigen and ALFQ adjuvant combination appears safe and immunogenic for adults in the ...
- Malaria: New vaccine candidate shows promise in clinical trialson September 14, 2022 at 10:00 am
A new malaria vaccine candidate for children aged 5–17 months has shown efficacy in phase 1 and 2 clinical trials, marking a step forward in the fight against this infectious disease.
- A New Malaria Vaccineon September 14, 2022 at 9:31 am
A second anti-malarial vaccine in just two years could be a game-changer for this deadly disease. In the 14 years of SBM we only have written two articles about malaria, both in 2021. At first this ...
via Bing News
